Prediction markets put the probability at 10%: New pandemic in 2026. Currently, markets see this as unlikely (10% YES). Wed, 20 May 2026 02:27:05 GMT (1779244025338).
A confluence of active viral outbreaks is fueling public discourse about the risk of a new pandemic in 2026. As of May 19, 2026, the World Health Organization has declared a public-health emergency of international concern over a new Ebola Bundibugyo outbreak centered in the Democratic Republic of the Congo, which has already sickened more than 500 people and killed 131, with confirmed spread into Uganda. Simultaneously, the Andes hantavirus outbreak originating on the cruise ship MV Hondius has involved individuals from more than 20 countries, with the vessel set to dock in Rotterdam for quarantine and disinfection. These parallel crises have prompted a VOTE by National News Desk asking whether the public has confidence in the CDC to contain another pandemic in the US, reflecting growing anxiety about the nation's ability to respond to a new pandemic in 2026 should one emerge. [National News Desk, Tue May 19]
The significance of these events is underscored by a May 18, 2026 report from the World Health Organization's Global Preparedness Monitoring Board, which warns that the world is not any more prepared for a pandemic than it was before COVID-19. The report states that investment in global health research, prevention, and preparedness has not kept pace with the increasing frequency and intensity of infectious disease epidemics, and that the "real, near term risk of another pandemic" is that it "would strike" a system still riddled with gaps. This assessment aligns with expert commentary in Time Magazine, which notes that the world is underprepared for threats that are already here, referencing the two major outbreaks currently underway. The Atlantic further reports that the Ebola outbreak in the DRC has likely been spreading undetected for weeks or months, suggesting that surveillance systems remain fragile. [Forbes, Mon May 18]
Looking ahead, the trajectory of these existing outbreaks will be a critical test of global response capabilities. The WHO and EU are coordinating quarantine measures for the hantavirus-affected cruise ship, while Africa CDC and the WHO are racing to contain the Ebola strain that has already crossed an international border. Experts cited in Time Magazine emphasize the importance of the "100 Days Mission"—a global goal to develop vaccines and treatments within 100 days of a pandemic threat—but note that current outbreaks are outpacing such timelines. The question of whether these events will escalate into a broader new pandemic in 2026 hinges on containment success in the coming weeks, as well as the ability of health authorities to detect and isolate cases before they spread further. [Time Magazine, Tue May 19]
Polymarket prices this at 12c YES with $585K in volume. Moderate liquidity — use limit orders for positions above $1K to avoid moving the price.
4/5 models agree on NO, fair value 13c vs market 10c. Weak edge — consider waiting for stronger signal.
| Model | Says | Fair Value estimated fair price | Confidence |
|---|---|---|---|
| MATH PIN Model | NO | 98c | — |
| MATH Compound Signal | NO | 72c | — |
| AI DeepSeek Quant | NO | 92c | 75% |
| AI Gemini Flash | ??? | 35c | 60% |
| AI Kimi Macro | NO | 85c | 65% |
4 of 5 models estimate NO fair value below market (72–98c vs 90c). DeepSeek Quant leads with 75% confidence.
Models estimate fair value of NO at 87c — market prices it at 90c. 3-point gap supports YES.
We tracked 1 wallet with positions above $1K on this market. NO wallets entered between 88c.
| Wallet | Category | Side | Amount | P&L | |
|---|---|---|---|---|---|
| 0xcaab..dd | MM | NO | $4.6K | +3% |
NO wallets entered at 88c. At current price 12c, all YES buyers are underwater while all NO holders are profitable. Profitable positions rarely sell early — NO side has structural price support.
Polymarket prices YES at 12c with $585K in total volume. Our model estimates fair value at 13c. 1-point gap is within normal range — no significant mispricing.
| Platform | YES Price | Volume |
|---|---|---|
| Polymarket | 12c | $585K |
| Our Model | 13c | — |